High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
High-flow Nasal Oxygenation for Apnoeic Oxygenation With Optiflow Switch During Intubation of the Critically Ill Adult- a Prospective Before-and-after Study
Region Stockholm
150 participants
Sep 25, 2023
OBSERVATIONAL
Conditions
Summary
Intubation in the intensive care unit is a standard procedure with a high risk of adverse events such as hypoxaemia and cardiovascular instability. However, it is demonstrated that HFNO (High Flow Nasal Oxygen) for pre and perioxygenation is feasible and, in many situations, prolongs the safe apnoeic period after anaesthesia induction. Previous data of the use of HFNO during intubation of the critically ill is conflicting. With the new device Optiflow Switch, which allow its combination with NIV or tight facemask with perioxygenation, we aim to evaluate whether this could reduce intubation-related hypoxaemia and other adverse events. The general purpose of this project is to compare the addition of Optiflow Switch for pre- and perioxygenation to traditional preoxygenation using a tight-fitting mask or NIV during intubation in adult intensive care patients in a prospective before-and-after study design.
Eligibility
Inclusion Criteria2
- Adult, ≥18 years old
- Intensive care patients that require tracheal intubation for any indication
Exclusion Criteria4
- Patients with skull or facial injuries where the application of nasal cannula is to be avoided, decided by the intensivist.
- Pregnancy
- Total nasal obstruction
- Deemed not suitable for any other reason than the aforementioned
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
High flow nasal oxygen with the Optiflow Switch device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05883137